Google+ Google+

Actos Recall Time?


I believe it’s time for an online campaign, including social media, to educate the public and push for a recall of the diabetes drug Actos®.

Actos was recalled in France and Germany in 2011 because of the risks of bladder cancer and congestive heart failure. The FDA, instead of recalling Actos, merely issued a warning.

Now two studies in June and July 2012 have confirmed the risk of bladder cancer, and another study in June 2012 shows that Actos increases the risk of macular edema, which causes blurred vision.

The Actos situation today reminds me of the Rezulin debacle in 2000. Rezulin, a diabetes drug with huge sales, was causing liver failure in some patients taking the drug.

At the time, Dr. Sidney Wolfe of Public Citizen’s Health Research Group had called on the FDA to recall Rezulin, but the FDA was slow to act., The drug company was denying the problems and fighting all recall efforts. Meanwhile, some patients taking Rezulin died and others had liver transplants.

I joined with a group of law firms to create what we called “The Rezulin Legal Alliance.” We put up two websites laying out the case for recalling Rezulin. And we offered to represent patients with liver damage due to the drug.

Eventually, Rezulin was recalled, and the Rezulin Legal Alliance law firms represented over 1,000 Rezulin victims with liver damage in successful litigation against the maker of the drug.

The Actos situation today reminds me very much of the Rezulin debacle. The maker of Actos is ignoring the problem, and the FDA has been slow to act. As in the case of Rezulin, we know the opinion of consumer advocate Dr. Sidney Wolfe. Actos has long been on his list of pills to avoid because he says there are safer alternatives available, such as metformin (Glucophage) and glipizide (Glucotrol).

The evidence against Actos keeps accumulating, yet the drug maker and the FDA have not recalled Actos. People who are concerned about the issue need to call on them to recall Actos.


Patients taking Actos should not stop taking it before consulting with their physician. Before meeting with your doctor, you may want to research the issue of the safety of Actos. I’ve posted links to some of the relevant articles below.

Actos® is one of the trade names under which the drug pioglitazone is marketed. ACTOS, ACTOplus met, ACTOplus met XR, and Duetact are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals U.S.A., Inc.

About Michael J. Evans

Michael J. Evans is a personal injury lawyer who represents people with claims involving defective medicine or medical devices, other defective products that cause serious injury or death, and environmental cases. Evans also handles whistleblower lawsuits in which employees, or former employees, expose fraud or other illegal conduct by the corporation for which they work(ed), Evans organizes litigation groups of plaintiffs law firms to work with him on these cases nationwide. Evans uses social media, blogs, online video, mobile apps and traditional media to connect with clients, and help other prominent law firms connect with clients.. Evans is also an advocate for the rights of consumers. His primary areas of legal practice are mass torts, and advising law firms on the ethical rules and law governing legal marketing via the Internet and social media.

Speak Your Mind


Attorney Advertising

No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. The hiring of a law firm is a serious decision that should not be based on advertising alone.